{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:41:46Z","timestamp":1792212106130,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57133-w","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:09:21Z","timestamp":1740305361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dual-mode action of scalable, high-quality engineered stem cell-derived SIRP\u03b1-extracellular vesicles for treating acute liver failure"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-1240","authenticated-orcid":false,"given":"Seohyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-1843","authenticated-orcid":false,"given":"Yoon Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2872-0806","authenticated-orcid":false,"given":"Seonghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6272-9984","authenticated-orcid":false,"given":"Yong-Soon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-6415","authenticated-orcid":false,"given":"Inkyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0963-187X","authenticated-orcid":false,"given":"Seryoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6448-4038","authenticated-orcid":false,"given":"Min Kyoung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-7233","authenticated-orcid":false,"given":"Yoonjeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Woong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Zakhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-5305","authenticated-orcid":false,"given":"Jiwan","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-3451","authenticated-orcid":false,"given":"Jeongbin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1772-2523","authenticated-orcid":false,"given":"Seung-Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-0175","authenticated-orcid":false,"given":"Gi Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-3818","authenticated-orcid":false,"given":"Gi-Hoon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-4521","authenticated-orcid":false,"given":"In-San","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,23]]},"reference":[{"key":"57133_CR1","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9, 7204\u20137218 (2018).","journal-title":"Oncotarget"},{"key":"57133_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrgastro.2009.127","volume":"6","author":"RT Stravitz","year":"2009","unstructured":"Stravitz, R. T. & Kramer, D. J. Management of acute liver failure. Nat. Rev. Gastroenterol. Hepatol. 6, 542\u2013553 (2009).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57133_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.126","volume":"6","author":"M Deutsch","year":"2015","unstructured":"Deutsch, M. et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 6, e1759 (2015).","journal-title":"Cell Death Dis."},{"key":"57133_CR4","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s00204-019-02597-1","volume":"93","author":"H Jaeschke","year":"2019","unstructured":"Jaeschke, H., Ramachandran, A., Chao, X. & Ding, W.-X. Emerging and established modes of cell death during acetaminophen-induced liver injury. Arch. Toxicol. 93, 3491\u20133502 (2019).","journal-title":"Arch. Toxicol."},{"key":"57133_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.316","volume":"6","author":"H Zhao","year":"2015","unstructured":"Zhao, H. et al. Role of necroptosis in the pathogenesis of solid organ injury. Cell Death Dis. 6, e1975 (2015).","journal-title":"Cell Death Dis."},{"key":"57133_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe, R. F. & Luedde, T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat. Rev. Gastroenterol. Hepatol. 15, 738\u2013752 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57133_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","volume":"27","author":"BD Gerlach","year":"2020","unstructured":"Gerlach, B. D. et al. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ. 27, 525\u2013539 (2020).","journal-title":"Cell Death Differ."},{"key":"57133_CR8","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 33, 2445\u20132463.e8 (2021).","journal-title":"Cell Metab."},{"key":"57133_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp8309","volume":"14","author":"H Shi","year":"2022","unstructured":"Shi, H. et al. CD47-SIRP\u03b1 axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Sci. Transl. Med. 14, eabp8309 (2022).","journal-title":"Sci. Transl. Med."},{"key":"57133_CR10","doi-asserted-by":"crossref","unstructured":"Weston, C. J., Zimmermann, H. W. & Adams, D. H. The role of myeloid-derived cells in the progression of liver disease. Front. Immunol. 10, 893 (2019).","DOI":"10.3389\/fimmu.2019.00893"},{"key":"57133_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen, Y., Lambrecht, J., Ju, C. & Tacke, F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol. Immunol. 18, 45\u201356 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"57133_CR12","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12579","volume":"9","author":"J Hefler","year":"2021","unstructured":"Hefler, J. et al. Preclinical models of acute liver failure: a comprehensive review. PeerJ 9, e12579 (2021).","journal-title":"PeerJ"},{"key":"57133_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11011-005-7927-z","volume":"20","author":"M B\u00e9langer","year":"2005","unstructured":"B\u00e9langer, M. & Butterworth, R. F. Acute liver failure: a critical appraisal of available animal models. Metab. Brain Dis. 20, 409\u2013423 (2005).","journal-title":"Metab. Brain Dis."},{"key":"57133_CR14","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gkac084","volume":"50","author":"S Bae","year":"2022","unstructured":"Bae, S. et al. CellDART: cell type inference by domain adaptation of single-cell and spatial transcriptomic data. Nucleic Acids Res. 50, e57\u2013e57 (2022).","journal-title":"Nucleic Acids Res."},{"key":"57133_CR15","doi-asserted-by":"publisher","unstructured":"Bae, S. et al. STopover captures spatial colocalization and interaction in the tumor microenvironment using topological analysis in spatial transcriptomics data. Preprint at biorxiv https:\/\/doi.org\/10.1101\/2022.11.16.516708 (2022).","DOI":"10.1101\/2022.11.16.516708"},{"key":"57133_CR16","doi-asserted-by":"crossref","unstructured":"Giatromanolaki, A. et al. Expression of CD47 and SIRP\u03b1 macrophage immune-checkpoint pathway in non-small-cell lung cancer. Cancers 14, 1801 (2022).","DOI":"10.3390\/cancers14071801"},{"key":"57133_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.tcb.2020.09.009","volume":"30","author":"MT Roefs","year":"2020","unstructured":"Roefs, M. T., Sluijter, J. P. G. & Vader, P. Extracellular vesicle-associated proteins in tissue repair. Trends Cell Biol. 30, 990\u20131013 (2020).","journal-title":"Trends Cell Biol."},{"key":"57133_CR18","doi-asserted-by":"crossref","unstructured":"Lee, I. et al. Small extracellular vesicles as a new class of medicines. Pharmaceutics 15, 325 (2023).","DOI":"10.3390\/pharmaceutics15020325"},{"key":"57133_CR19","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"57133_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800163","volume":"19","author":"BWM Van Balkom","year":"2019","unstructured":"Van Balkom, B. W. M., Gremmels, H., Giebel, B. & Lim, S. K. Proteomic signature of mesenchymal stromal cell-derived small extracellular vesicles. Proteomics 19, e1800163 (2019).","journal-title":"Proteomics"},{"key":"57133_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jconrel.2022.09.042","volume":"351","author":"YK Kim","year":"2022","unstructured":"Kim, Y. K. et al. Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy. J. Control Release 351, 727\u2013738 (2022).","journal-title":"J. Control Release"},{"key":"57133_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/j.1478-3231.2006.01342.x","volume":"26","author":"M Bilzer","year":"2006","unstructured":"Bilzer, M., Roggel, F. & Gerbes, A. L. Role of Kupffer cells in host defense and liver disease. Liver Int. 26, 1175\u20131186 (2006).","journal-title":"Liver Int."},{"key":"57133_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41565-023-01585-y","volume":"19","author":"R Liam-Or","year":"2024","unstructured":"Liam-Or, R. et al. Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nat. Nanotechnol. 19, 846\u2013855 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"57133_CR24","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/hep.23754","volume":"52","author":"A Dech\u00eane","year":"2010","unstructured":"Dech\u00eane, A. et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52, 1008\u20131016 (2010).","journal-title":"Hepatology"},{"key":"57133_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16092-0","volume":"11","author":"P An","year":"2020","unstructured":"An, P. et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat. Commun. 11, 2362 (2020).","journal-title":"Nat. Commun."},{"key":"57133_CR26","doi-asserted-by":"crossref","unstructured":"Feng, D. et al. Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models. J. Clin. Investig. 133, e166954 (2023).","DOI":"10.1172\/JCI166954"},{"key":"57133_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/bmj.2.6198.1097","volume":"2","author":"LF Prescott","year":"1979","unstructured":"Prescott, L. F. et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br. Med. J. 2, 1097\u20131100 (1979).","journal-title":"Br. Med. J."},{"key":"57133_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aav8075","volume":"12","author":"K Arnold","year":"2020","unstructured":"Arnold, K. et al. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure. Sci. Transl. Med. 12, 1\u201312 (2020).","journal-title":"Sci. Transl. Med."},{"key":"57133_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2020.02.031","volume":"73","author":"P Starkey Lewis","year":"2020","unstructured":"Starkey Lewis, P. et al. Alternatively activated macrophages promote resolution of necrosis following acute liver injury. J. Hepatol. 73, 349\u2013360 (2020).","journal-title":"J. Hepatol."},{"key":"57133_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nri.2017.42","volume":"17","author":"M Guilliams","year":"2017","unstructured":"Guilliams, M. & Scott, C. L. Does niche competition determine the origin of tissue-resident macrophages? Nat. Rev. Immunol. 17, 451\u2013460 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"57133_CR31","doi-asserted-by":"crossref","unstructured":"Flores Molina, M. et al. Distinct spatial distribution and roles of Kupffer cells and monocyte-derived macrophages in mouse acute liver injury. Front. Immunol. 13, 994480 (2022).","DOI":"10.3389\/fimmu.2022.994480"},{"key":"57133_CR32","doi-asserted-by":"publisher","first-page":"113164","DOI":"10.1016\/j.celrep.2023.113164","volume":"42","author":"W Li","year":"2023","unstructured":"Li, W., Yang, Y., Yang, L., Chang, N. & Li, L. Monocyte-derived Kupffer cells dominate in the Kupffer cell pool during liver injury. Cell Rep. 42, 113164 (2023).","journal-title":"Cell Rep."},{"key":"57133_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2023.123238","volume":"310","author":"RM Silva","year":"2023","unstructured":"Silva, R. M. et al. Anion exchange chromatography-based platform for the scalable purification of extracellular vesicles derived from human mesenchymal stromal cells. Sep Purif. Technol. 310, 123238 (2023).","journal-title":"Sep Purif. Technol."},{"key":"57133_CR34","doi-asserted-by":"crossref","unstructured":"Watson, D. C. et al. Scalable, cGMP\u2010compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL\u201015\/lactadherin complexes. J. Extracell. Vesicles 7, 1442088 (2018).","DOI":"10.1080\/20013078.2018.1442088"},{"key":"57133_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/cells7120273","volume":"7","author":"S Busatto","year":"2018","unstructured":"Busatto, S. et al. Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells 7, 273 (2018).","journal-title":"Cells"},{"key":"57133_CR36","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.copbio.2022.102776","volume":"77","author":"S Estes","year":"2022","unstructured":"Estes, S., Konstantinov, K. & Young, J. D. Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities. Curr. Opin. Biotechnol. 77, 102776 (2022).","journal-title":"Curr. Opin. Biotechnol."},{"key":"57133_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5731\/pdajpst.2013.00910","volume":"67","author":"H Yang","year":"2013","unstructured":"Yang, H. Establishing acceptable limits of residual DNA. PDA J. Pharm. Sci. Technol. 67, 155\u2013163 (2013).","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"57133_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57497-7","volume":"10","author":"K Brennan","year":"2020","unstructured":"Brennan, K. et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci. Rep. 10, 1039 (2020).","journal-title":"Sci. Rep."},{"key":"57133_CR39","doi-asserted-by":"crossref","unstructured":"Webber, J. & Clayton, A. How pure are your vesicles? J. Extracell. Vesicles 2, 19861 (2013).","DOI":"10.3402\/jev.v2i0.19861"},{"key":"57133_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biomaterials.2017.01.004","volume":"121","author":"E Koh","year":"2017","unstructured":"Koh, E. et al. Exosome-SIRP\u03b1, a CD47 blockade increases cancer cell phagocytosis. Biomaterials 121, 121\u2013129 (2017).","journal-title":"Biomaterials"},{"key":"57133_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202300527","volume":"19","author":"GB Kim","year":"2023","unstructured":"Kim, G. B. et al. Harnessing oncolytic extracellular vesicles for tumor cell-preferential cytoplasmic delivery of misfolded proteins for cancer immunotherapy. Small 19, e2300527 (2023).","journal-title":"Small"},{"key":"57133_CR42","doi-asserted-by":"publisher","unstructured":"Yang, Y. et al. Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv. Mater. 29, https:\/\/doi.org\/10.1002\/adma.201605604 (2017).","DOI":"10.1002\/adma.201605604"},{"key":"57133_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jconrel.2018.04.037","volume":"279","author":"E Cho","year":"2018","unstructured":"Cho, E. et al. Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics. J. Controlled Release 279, 326\u2013335 (2018).","journal-title":"J. Controlled Release"},{"key":"57133_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002440","volume":"32","author":"G-H Nam","year":"2020","unstructured":"Nam, G.-H. et al. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv. Mater. 32, e2002440 (2020).","journal-title":"Adv. Mater."},{"key":"57133_CR45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16, 748\u2013759 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"57133_CR46","doi-asserted-by":"crossref","unstructured":"Kim, G. B. et al. Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. Sci. Adv. 6, eaaz2083 (2020).","DOI":"10.1126\/sciadv.aaz2083"},{"key":"57133_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2020.05.036","volume":"489","author":"YK Kim","year":"2020","unstructured":"Kim, Y. K., Choi, Y., Nam, G.-H. & Kim, I.-S. Functionalized exosome harboring bioactive molecules for cancer therapy. Cancer Lett. 489, 155\u2013162 (2020).","journal-title":"Cancer Lett."},{"key":"57133_CR48","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham, S. B. et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. USA 109, 6662\u20136667 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57133_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16466-4","volume":"11","author":"L Cui","year":"2020","unstructured":"Cui, L. et al. Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity. Nat. Commun. 11, 2795 (2020).","journal-title":"Nat. Commun."},{"key":"57133_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","volume":"14","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z., Sun, H., Yu, J., Tian, W. & Song, Y. Targeting CD47 for cancer immunotherapy. J. Hematol. Oncol. 14, 180 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"57133_CR51","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.iotech.2022.100070","volume":"13","author":"R Maute","year":"2022","unstructured":"Maute, R., Xu, J. & Weissman, I. L. CD47-SIRP\u03b1-targeted therapeutics: status and prospects. Immuno-Oncol. Technol. 13, 100070 (2022).","journal-title":"Immuno-Oncol. Technol."},{"key":"57133_CR52","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/liv.12731","volume":"35","author":"Y He","year":"2015","unstructured":"He, Y. et al. Mechanisms of fibrosis in acute liver failure. Liver Int. 35, 1877\u20131885 (2015).","journal-title":"Liver Int."},{"key":"57133_CR53","doi-asserted-by":"publisher","first-page":"e49611","DOI":"10.1371\/journal.pone.0049611","volume":"7","author":"O Nissim","year":"2012","unstructured":"Nissim, O. et al. Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS ONE 7, e49611 (2012).","journal-title":"PLoS ONE"},{"key":"57133_CR54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.stem.2022.04.008","volume":"29","author":"S Ben-Moshe","year":"2022","unstructured":"Ben-Moshe, S. et al. The spatiotemporal program of zonal liver regeneration following acute injury. Cell Stem Cell 29, 973\u2013989.e10 (2022).","journal-title":"Cell Stem Cell"},{"key":"57133_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jim.2019.04.007","volume":"470","author":"G-H Nam","year":"2019","unstructured":"Nam, G.-H. et al. An optimized protocol to determine the engulfment of cancer cells by phagocytes using flow cytometry and fluorescence microscopy. J. Immunol. Methods 470, 27\u201332 (2019).","journal-title":"J. Immunol. Methods"},{"key":"57133_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04607-9","volume":"9","author":"G-H Nam","year":"2018","unstructured":"Nam, G.-H. et al. Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer. Nat. Commun. 9, 2165 (2018).","journal-title":"Nat. Commun."},{"key":"57133_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1238856","volume":"341","author":"K Weiskopf","year":"2013","unstructured":"Weiskopf, K. et al. Engineered SIRP\u03b1 variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341, 88\u201391 (2013).","journal-title":"Science"},{"key":"57133_CR58","unstructured":"Kim, I. S., Park, S., Nam, G. H. & Lee, I. Surface-engineered extracellular vesicles and therapeutic uses thereof. US Patent 20230381226A1, United States Patent and Trademark Office (2023)."},{"key":"57133_CR59","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/S1465-3249(22)00267-5","volume":"24","author":"S Lenzini","year":"2022","unstructured":"Lenzini, S. et al. Exosomes\/EVs: developing a microcarrier stirred tank process for large-scale hMSC-EV production. Cytotherapy 24, S91 (2022).","journal-title":"Cytotherapy"},{"key":"57133_CR60","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/S1465-3249(22)00220-1","volume":"24","author":"R Wagey","year":"2022","unstructured":"Wagey, R. et al. Mesenchymal stem\/stromal cells: suspension culture of human mesenchymal stromal cells on dissolvable microcarriers in an animal component-free culture system. Cytotherapy 24, S71\u2013S72 (2022).","journal-title":"Cytotherapy"},{"key":"57133_CR61","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jcyt.2019.03.464","volume":"21","author":"RD Kirian","year":"2019","unstructured":"Kirian, R. D. et al. Scaling a xeno-free fed-batch microcarrier suspension bioreactor system from development to production scale for manufacturing XF hMSCs. Cytotherapy 21, S71\u2013S72 (2019).","journal-title":"Cytotherapy"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57133-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:09:27Z","timestamp":1740305367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57133-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57133"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57133-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.24.592430","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,23]]},"assertion":[{"value":"7 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.-S.K. and G.-H.N. are the co-founders and have stock interest in SHIFTBIO INC. S.K. (Seohyun Kim), Y.K.K., S.K. (Seonghyun Kim), Y.-S.C., I.L., H.J., J.K., Y.C., and G.B.K. are employees of SHIFTBIO INC. T.D.S., J.J., E.Z., and S.L. are employees of RoosterBio, Inc. H.C. are the co-founder and have stock interest in Portrai, Inc. J.P. is an employee of Portrai, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1903"}}